Effect of Electroacupuncture on Sensitive Symptoms of Distal Diabetic Peripheral Neuropathy

Summary

This is a controlled clinical trial with the aim to study the effects of electroacupuncture on neuropathic pain reduction, quality of life and changes in sensory and motor nerve conduction velocity in patients with type 2 diabetes mellitus, beneficiaries of the familiar medical centers 20, 40 and 41 of the Instituto Mexicano del Seguro Social, at north of Mexico City, in colaboration with the human acupuncture specialty of the Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Mexico.

Conditions

• Electroacupuncture
• Acupuncture
• Diabetic Polyneuropathy
• Diabetic Peripheral Neuropathy
• Diabetic Peripheral Neuropathic Pain
• Nerve Conduction

Interventions

PROCEDURE

Electroacupuncture

Intervention consists of a total of 32 sessions, divided into two intervention cycles, that is, 16 sessions over two months, with a rest period of one month in between. EA is applied for 20 minutes at an alternating frequency of 2 Hz. Acupunctural points are Zusanli (E36), Fenlong (E40), Yinlingquan (B9), Sanyinjiao (B6), Taichong (H3) and Zulinqi (VB41).

PROCEDURE

Sham Acupuncture

Intervention consists of a total of 32 sessions, divided into two intervention cycles, that is, 16 sessions over two months, with a rest period of one month in between. Sham acupuncture will be applied using a nonpuncture device without electrical stimulation at the same acupunctural points as in the EA group.

Sponsors & Collaborators

• National Polytechnic Institute, Mexico

  collaborator OTHER

• Instituto Nacional de Salud Publica, Mexico

  collaborator OTHER

• Escuela Superior de Medicina, Instituto Politécnico Nacional

  collaborator UNKNOWN

• Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional

  collaborator UNKNOWN

• Universidad Nacional Autonoma de Mexico

  collaborator OTHER

• Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de Mexico

  collaborator UNKNOWN

• Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de Mexico

  collaborator UNKNOWN

• Facultad de Medicina, UNAM

  collaborator UNKNOWN

• Instituto Mexicano del Seguro Social

  lead OTHER_GOV

Principal Investigators

• José de Jesús Peralta Romero, PhD · Instituto Mexicano del Seguro Social

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Model

PARALLEL

Eligibility

Min Age

40 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-11-01

Primary Completion

2024-12-31

Completion

2025-12-31

Countries

• Mexico

Study Locations